19
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Systematic development of an evidence-based website on preconception care

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction

          In February 2015, the Flemish Minister of Welfare, Public Health and Family launched a website on preconception care: ‘gezondzwangerworden.be’. The website was developed in response to the lack of comprehensive communication on preconception care and the inadequate intake of folic acid among Flemish women. Despite the international recommendation to take 400 μg folic acid on a daily basis one month before conception until 12 weeks of pregnancy, studies show a lack of compliance in women wanting to become pregnant.

          Procedure

          A compilation of evidence was made through reviewing well-established guidelines on preconception and prenatal care. The quality of guidelines was assessed by means of AGREE II. The topics included in the website were selected by an internal committee of 5 experts and an external committee of 16 experts. Content validation was carried out by 40 experts in preconception care or related topics.

          Results

          The above-described procedure resulted in an evidence-based website with a selection of relevant, validated information for both women and men who plan a pregnancy and professionals who are consulted by these people.

          Evaluation and recommendation

          The website is currently attracting a constant number of 100 to 200 visitors a day. The information on folic acid is among the most requested, which is an important finding with regard to the policy objectives on preconception care. More research is needed in order to evaluate the use and effect of the website more thoroughly.

          Related collections

          Most cited references3

          • Record: found
          • Abstract: found
          • Article: not found

          Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group.

          A randomised double-blind prevention trial with a factorial design was conducted at 33 centres in seven countries to determine whether supplementation with folic acid (one of the vitamins in the B group) or a mixture of seven other vitamins (A,D,B1,B2,B6,C and nicotinamide) around the time of conception can prevent neural tube defects (anencephaly, spina bifida, encephalocele). A total of 1817 women at high risk of having a pregnancy with a neural tube defect, because of a previous affected pregnancy, were allocated at random to one of four groups--namely, folic acid, other vitamins, both, or neither. 1195 had a completed pregnancy in which the fetus or infant was known to have or not have a neural tube defect; 27 of these had a known neural tube defect, 6 in the folic acid groups and 21 in the two other groups, a 72% protective effect (relative risk 0.28, 95% confidence interval 0.12-0.71). The other vitamins showed no significant protective effect (relative risk 0.80, 95% Cl 0.32-1.72). There was no demonstrable harm from the folic acid supplementation, though the ability of the study to detect rare or slight adverse effects was limited. Folic acid supplementation starting before pregnancy can now be firmly recommended for all women who have had an affected pregnancy, and public health measures should be taken to ensure that the diet of all women who may bear children contains an adequate amount of folic acid.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The clinical content of preconception care: an overview and preparation of this supplement.

            In June 2005, the Select Panel on Preconception Care established implementation workgroups in 5 areas (clinical, public health, consumer, policy and finance, and research and surveillance) to develop strategies for the implementation of the Centers for Disease Control and Prevention recommendations on preconception health and healthcare. In June 2006, members of the clinical workgroup asked the following questions: what are the clinical components of preconception care? What is the evidence for inclusion of each component in clinical activities? What health promotion package should be delivered as part of preconception care? Over the next 2 years, the 29 members of the clinical workgroup and > 30 expert consultants reviewed in depth > 80 topics that make up the content of the articles that are contained in this supplement. Topics were selected on the basis of the effect of preconception care on the health of the mother and/or infant, prevalence, and detectability. For each topic, the workgroup assigned a score for the strength of the evidence that supported its inclusion in preconception care and assigned a strength of the recommendation. This article summarizes the methods that were used to select and review each topic and provides a summary table of the recommendations.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Appraising a tool for guideline appraisal (the AGREE II instrument).

                Bookmark

                Author and article information

                Journal
                Ups J Med Sci
                Ups. J. Med. Sci
                IUPS
                Upsala Journal of Medical Sciences
                Taylor & Francis
                0300-9734
                2000-1967
                November 2016
                30 August 2016
                : 121
                : 4
                : 264-270
                Affiliations
                [a ]Department of Midwifery, Health Education, Vives University College, Kortrijk, Belgium;
                [b ]Department of Obstetrics and Gynecology, Ghent University Hospital, Ghent, Belgium;
                [c ]Department of Family Medicine and Primary Health Care, Ghent University, Ghent, Belgium;
                [d ]Department of Agricultural Economics, Faculty of Biosciences Engineering, Ghent University, Ghent, Belgium;
                [e ]University Centre for Nursing and Midwifery, Department of Public Health, Ghent University, Ghent, Belgium;
                [f ]Public Health Agency ‘Zorg & Gezondheid’, Flemish Government, Brussels, Belgium
                Author notes
                CONTACT Ilse Delbaere ilse.delbaere@ 123456vives.be Department of Midwifery, Health Education, Vives University College, Kortrijk, Belgium
                Author information
                http://orcid.org/0000-0002-2540-8307
                http://orcid.org/0000-0002-8908-3310
                Article
                iups-121-264
                10.1080/03009734.2016.1216481
                5098491
                27586661
                9c86342c-0d08-4109-9e4a-7c7892b59469
                © 2016 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 21 April 2016
                : 01 July 2016
                : 17 July 2016
                Categories
                Original Articles

                Medicine
                evidence-based,folic acid,guideline,information,preconception care,prevention
                Medicine
                evidence-based, folic acid, guideline, information, preconception care, prevention

                Comments

                Comment on this article